WallStSmart

Diebold Nixdorf, Incorporated (DBD)vsUber Technologies Inc (UBER)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Uber Technologies Inc generates 1326% more annual revenue ($55.23B vs $3.87B). UBER leads profitability with a 17.3% profit margin vs 2.9%. UBER trades at a lower P/E of 15.3x. UBER earns a higher WallStSmart Score of 64/100 (C+).

DBD

Buy

54

out of 100

Grade: C-

Growth: 6.0Profit: 5.5Value: 5.3Quality: 5.0
Piotroski: 4/9Altman Z: 1.57

UBER

Buy

64

out of 100

Grade: C+

Growth: 8.0Profit: 7.5Value: 5.3Quality: 4.5
Piotroski: 4/9Altman Z: 1.47
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for DBD.

UBERUndervalued (+2.9%)

Margin of Safety

+2.9%

Fair Value

$71.39

Current Price

$70.34

$1.05 discount

UndervaluedFair: $71.39Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DBD2 strengths · Avg: 8.0/10
Price/BookValuation
2.3x8/10

Reasonable price relative to book value

EPS GrowthGrowth
34.2%8/10

Earnings expanding 34.2% YoY

UBER5 strengths · Avg: 9.0/10
Return on EquityProfitability
35.1%10/10

Every $100 of equity generates 35 in profit

EPS GrowthGrowth
85.5%10/10

Earnings expanding 85.5% YoY

Market CapQuality
$141.10B9/10

Large-cap with strong market position

P/E RatioValuation
15.3x8/10

Attractively priced relative to earnings

Free Cash FlowQuality
$2.79B8/10

Generating 2.8B in free cash flow

Areas to Watch

DBD4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
1.7%4/10

1.7% revenue growth

Altman Z-ScoreHealth
1.574/10

Distress zone — elevated risk

Profit MarginProfitability
2.9%3/10

2.9% margin — thin

Debt/EquityHealth
1.143/10

Elevated debt levels

UBER2 concerns · Avg: 2.0/10
PEG RatioValuation
5.922/10

Expensive relative to growth rate

Altman Z-ScoreHealth
1.472/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : DBD

The strongest argument for DBD centers on Price/Book, EPS Growth.

Bull Case : UBER

The strongest argument for UBER centers on Return on Equity, EPS Growth, Market Cap. Profitability is solid with margins at 17.3% and operating margin at 13.3%. Revenue growth of 12.2% demonstrates continued momentum.

Bear Case : DBD

The primary concerns for DBD are Revenue Growth, Altman Z-Score, Profit Margin. Thin 2.9% margins leave little buffer for downturns.

Bear Case : UBER

The primary concerns for UBER are PEG Ratio, Altman Z-Score.

Key Dynamics to Monitor

DBD profiles as a value stock while UBER is a mature play — different risk/reward profiles.

UBER carries more volatility with a beta of 1.26 — expect wider price swings.

UBER is growing revenue faster at 12.2% — sustainability is the question.

UBER generates stronger free cash flow (2.8B), providing more financial flexibility.

Bottom Line

UBER scores higher overall (64/100 vs 54/100), backed by strong 17.3% margins and 12.2% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Diebold Nixdorf, Incorporated

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Diebold Nixdorf, Incorporated provides connected commerce solutions to financial institutions and retailers in Western Europe, Eastern Europe, Asia, the Middle East, Africa, the United States, Canada, Mexico and Latin America. The company is headquartered in North Canton, Ohio.

Uber Technologies Inc

TECHNOLOGY · SOFTWARE - APPLICATION · USA

Uber Technologies, Inc., commonly known as Uber, is an American technology company. Its services include ride-hailing, food delivery (Uber Eats), package delivery, couriers, freight transportation, and, through a partnership with Lime, electric bicycle and motorized scooter rental. The company is based in San Francisco, California.

Visit Website →

Want to dig deeper into these stocks?